Action Diagnos - ADK

Diagnos Inc (ADK) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,215

( -4,44% )

Prix Achat

0,215

Prix Vente

0,22

Volume échangé

216 500

0,215 Fourchette du Jour 0,23

0,00 Plage de 52 semaines 0,00

Cap du marché

25,889M

Clôture Veille

0,225

Ouverture

0,225

Dernière Transaction

2000

0.215

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

$ 217 615

Actions en circulation

120 412 549

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-4,92

Bénéfice par action (BPA)

-0,04

Chiffre d'affairess (LTM)

68,16k

Bénéfice net (LTM)

-4,71M

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic... DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada. Show more

Secteur

Healthcare

Industrie

Healthcare Providers & Services

Site Web

www.diagnos.com

Siège social

Brossard, Canada

Fondé

1998

Diagnos Inc est coté dans le secteur Healthcare de la TSX Venture Exchange avec le ticker ADK. Le dernier cours de clôture d'Diagnos était de $0,23. Au cours de la dernière année, les actions de Diagnos ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Diagnos compte actuellement 120 412 549 actions en circulation. La capitalisation boursière d'Diagnos est de $25,89 million. Diagnos a un ratio cours/bénéfice (ratio PE) de -4.92.

DIAGNOS Announces Amendment to Convertible Debentures

BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA

BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration

BROSSARD, Quebec, April 01, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants

BROSSARD, Quebec, March 05, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference

BROSSARD, Quebec, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation

BROSSARD, Quebec, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces the Engagement of IBN

BROSSARD, Quebec, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress

BROSSARD, Quebec, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare

BROSSARD, Quebec, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital

Not for distribution to United States newswire services or for dissemination in the United States. BROSSARD...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ADK - Frequently Asked Questions (FAQ)

What is the current Diagnos Inc share price?

The current share price of Diagnos Inc is $ 0,215

How many Diagnos Inc shares are in issue?

Diagnos Inc has 120 412 549 shares in issue

What is the market cap of Diagnos Inc?

The market capitalisation of Diagnos Inc is CAD 25,89M

What is the 1 year trading range for Diagnos Inc share price?

Diagnos Inc has traded in the range of $ 0,00 to $ 0,00 during the past year

What is the PE ratio of Diagnos Inc?

The price to earnings ratio of Diagnos Inc is -4,92

What is the cash to sales ratio of Diagnos Inc?

The cash to sales ratio of Diagnos Inc is 388,66

What is the registered address of Diagnos Inc?

The registered address for Diagnos Inc is 7005 Taschereau Boulevard, Brossard, Quebec, J4Z 1A7

What is the Diagnos Inc website address?

The website address for Diagnos Inc is www.diagnos.com

Which industry sector does Diagnos Inc operate in?

Diagnos Inc operates in the Healthcare Providers & Services sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Diagnos Inc (ADK)

Diagnos Inc (ADK) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Diagnos Inc

ADK Dernières nouvelles

DIAGNOS Announces Amendment to Convertible Debentures

DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA

DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration

DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants

DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference

DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation

DIAGNOS Announces the Engagement of IBN

DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress

DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare

Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital

DIAGNOS Announces Amendment to Convertible Debentures

DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA

DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration

DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants

DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference

DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation

DIAGNOS Announces the Engagement of IBN

DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress

DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare

Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital

Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital

DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025

ADK - Frequently Asked Questions (FAQ)

ADK Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS